Orikami

Nijmegen, Netherlands Founded: 2019 • Age: 7 yrs
Digital biomarkers are utilized for disease detection and measurement.
Annual revenue - Latest available
Total funding $654,492 2 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 2 Services tracked
Competitors 8 Brand Intelligence

About Orikami

Orikami is a company based in Nijmegen (Netherlands) founded in 2019. Orikami has raised $654.49 thousand across 2 funding rounds from investors including CbusineZ and Healthy.Capital. Orikami offers products and services including Digital Biomarkers and Data Science Services. Orikami operates in a competitive market with competitors including MedWhat, Applied Pathways, GenID Solutions, Open Source Health and IEEARC, among others.

  • Headquarter Nijmegen, Netherlands
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $654.49 K (USD)

    in 2 rounds

  • Latest Funding Round
    Not available
  • Investors
    CbusineZ

    & 1 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Orikami

Orikami offers a comprehensive portfolio of products and services, including Digital Biomarkers and Data Science Services.

Product name locked
Category locked
Primary

Objective data from digital devices for personalized healthcare decisions.

Product name locked
Category locked
Locked

Utilizes patient data to optimize healthcare paths and outcomes.

Funding Insights of Orikami

Orikami has successfully raised a total of $654.49K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Orikami

Orikami has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include CbusineZ and Healthy.Capital.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Healthy.Capital is focused on investing in digital health startups.
Locked Locked Locked
Invests in and supports early stage healthcare innovations in Dutch sector.
Locked Locked Locked
Premium access

Investor details for Orikami

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Orikami

Investments
Premium access

Investment portfolio details for Orikami

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Orikami

Premium access

Detailed financials for Orikami

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Orikami Comparisons

Orikami Primary company
Description
Digital biomarkers are utilized for disease detection and me...
Location
Nijmegen, Netherlands
Founded Year
2019
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Orikami

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Orikami

Orikami operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MedWhat, Applied Pathways, GenID Solutions, Open Source Health and IEEARC, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
AI based personal medical assistant application
Locked Locked Locked
Offers a cloud-based platform for clinical rules modeling and enterprise knowledge management.
Locked Locked Locked
Delivers a clinical decision support tool for disease detection.
Locked Locked Locked
Online platform for women health assistance to deliver precision medicine.
Locked Locked Locked
Lifestyle diseases are monitored via cloud-based health analytics platform.
Premium access

Detailed competitors of Orikami

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Orikami

Premium access

Complete news archive for Orikami

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Orikami

Orikami was founded in 2019.

Orikami is headquartered in Nijmegen, Netherlands. It is registered at Nijmegen, Gelderland, Netherlands.

Bram Den Teuling is the current CEO of Orikami.

Orikami is a funded company, having raised a total of $654.49K across 2 funding rounds to date.

Orikami was founded in 2019 in Nijmegen, Netherlands, focusing on the healthcare sector. Software has been developed by the company to assist providers in measuring and quantifying diseases. This enables informed decision-making processes through digital biomarkers. Operations center on disease detection and assessment tools, with the domain orikami.ai serving as the primary online presence. Leadership is provided by CEO Bram Den Teuling.

Orikami's top competitors include MedWhat, Khure Health and Lead Horse Technologies.

Orikami offers Digital Biomarkers and Data Science Services.

Orikami has 2 investors. Key investors include CbusineZ, and Healthy.Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available